You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cardiac toxicities

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)

Enrolling by invitation
  • Breast Cancer
  • +4 more
  • Tanta, Egypt
    Tanta university
Oct 22, 2022

Lymphoma Patients Undergoing Mediastinal Radiotherapy in Era of

Suspended
  • Mediastinal Lymphoma
  • +2 more
  • Standard treatment protocol with combined chemoradiation
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 8, 2022

Doxorubicin Induced Cardiomyopathy, Breast Cancer, Gastric Cancer Trial in Detroit (Exercise)

Completed
  • Doxorubicin Induced Cardiomyopathy
  • +3 more
  • Exercise
  • Detroit, Michigan
    William Clay Ford Center for Athletic Medicine
Dec 12, 2018

Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)

Not yet recruiting
  • Lung Cancer
  • Hypofractionated accelerated radiation therapy
  • Palo Alto, California
    Stanford University
Oct 11, 2023

Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Arterial Doppler for Flow Mediated Reserve measurement
  • Paris, France
    INstitut Mutualiste Montsouris
Aug 29, 2023

Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed

Recruiting
  • Cancer
  • +6 more
  • Cardiology consultation
  • +4 more
  • Deinze, East-Flanders, Belgium
  • +3 more
Jan 26, 2023

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Esophageal Cancer Trial in Indianapolis, Iowa City, Ann Arbor (Durvalumab)

Completed
Has Results
  • Esophageal Cancer
  • Indianapolis, Indiana
  • +2 more
May 5, 2022

Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

Recruiting
  • Non Small Cell Lung Cancer
  • Radiotherapy
  • +5 more
  • Newcastle Upon Tyne, United Kingdom
    Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
Sep 20, 2022

Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases Trial in Amsterdam, Leiden (Cardiac condition measurements)

Recruiting
  • Lung Cancer Stage I
  • +2 more
  • Cardiac condition measurements
  • Amsterdam, Netherlands
  • +2 more
Jul 9, 2021

GSD1 Trial in Worldwide (DTX401)

Completed
Has Results
  • GSD1
  • DTX401
  • steroid regimen
  • Farmington, Connecticut
  • +5 more
Oct 25, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Los Angeles, California
  • +3 more
Aug 22, 2022

Mitochondrial dysfUnction:Key Player in Doxorubicin-induced

Not yet recruiting
  • Doxorubicin Induced Cardiomyopathy
  • +3 more
  • 31-MRS at 7 Tesla (T)
  • Utrecht, Netherlands
  • +1 more
Feb 7, 2023

Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Hepatoma
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Oct 15, 2021

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Recruiting
  • DLBCL
  • +8 more
  • Cardiac MRI
  • Bonn, NRW, Germany
    University Hospital Bonn
Jun 11, 2022

CAR T Cell Therapy Related Cardiovascular Outcomes

Recruiting
  • Cardiovascular Diseases
  • +7 more
    • London, United Kingdom
      University College London Hospitals
    Nov 18, 2021

    NSCLC Trial in Cleveland (Durvalumab, Proton beam therapy RT)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 5, 2022

    Evaluation of High Dose Methotrexate Toxicity

    Not yet recruiting
    • Methotrexate Toxicity
    • blood methotrexate level and Cystatin C level
    • (no location specified)
    Nov 7, 2023

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Montbéliard (Chemotherapy, Stereotactic radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Montbéliard, France
      Hôpital Nord Franche Comté
    Mar 10, 2022

    Proteasome Inhibition

    Completed
    • Heart Failure
    • Multiple Myeloma
      • Philadelphia, Pennsylvania
      • +1 more
      Sep 10, 2020

      Small-cell Lung Cancer Trial in Atlanta (Proton-beam Therapy for Small Cell Lung Cancer)

      Recruiting
      • Small-cell Lung Cancer
      • Proton-beam Therapy for Small Cell Lung Cancer
      • Atlanta, Georgia
        Winship Cancer Institute
      Feb 18, 2022

      Breast Tumors, Radiotherapy, Lymph Node Metastases Trial in Ghent (Prone Radiotherapy, Acceleration, Supine Radiotherapy)

      Completed
      • Breast Neoplasms
      • +2 more
      • Prone Radiotherapy
      • +3 more
      • Ghent, Oost-Vlaanderen, Belgium
        Radiotherapy department, UZ Ghent
      Dec 9, 2022

      Relapsed/Refractory Multiple Myeloma Trial in United States (KITE-585, Cyclophosphamide, Fludarabine)

      Terminated
      Has Results
      • Relapsed/Refractory Multiple Myeloma
      • KITE-585
      • +2 more
      • Los Angeles, California
      • +8 more
      Oct 4, 2022